SCHEMBL3342474

SCHEMBL3342474

Cc1ccc(-n2cccc2)cc1C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.47
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
MAPK1 P28482 2/20 0.47
HPGD P15428 2/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
AOC2 O75106 4/20 0.41
MAPT P10636 3/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
SIRT3 Q9NTG7 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HTT P42858 2/20 0.39
NSD2 O96028 1/20 0.39
GRK2 P25098 1/20 0.39
CASP6 P55212 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3344595 0.81 L3MBTL1 (0.47) POLBALDH1A1KDM4EHPGDMEN1
SCHEMBL6522040 0.81 F10 (0.43) ALDH1A1MAPK1HPGDMEN1KMT2A
SCHEMBL9454140 0.80 MAPT (0.58) POLBALDH1A1KDM4EMAPK1HPGD
SCHEMBL13893786 0.80 POLB (0.45) POLBALDH1A1KDM4EMAPK1HPGD
SCHEMBL1788237 0.79 ALDH1A1 (0.59) POLBALDH1A1KDM4EMAPK1HPGD
SCHEMBL1784774 0.79 ALDH1A1 (0.47) POLBALDH1A1KDM4EMAPK1HPGD
SCHEMBL6524527 0.76 CASP1 (0.40) POLBALDH1A1MAPK1HPGDHSD17B10
SCHEMBL3342457 0.76 LRRK2 (0.47) ALDH1A1KDM4EMAPK1MEN1KMT2A
SCHEMBL3343037 0.76 PDE4A (0.44) SIRT3TDP1
SCHEMBL3343696 0.75 IP6K1 (0.55) ALDH1A1KDM4EMAPK1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010085968-A1 TOLUIDINE SULFONAMIDES AND THEIR USE AS HIF-INHIBITORS EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) (DE) 2010-08-05 WO disclosed
WO-2010076034-A1 TOLUIDINE SULFONAMIDES AND THEIR USE AS-INHIBITORS EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) (DE) 2010-07-08 WO disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 POLB 4104/4885ALDH1A1 1506/4885KDM4E 2591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.